Bortezomib, Lenalidomide plus low-dose dexamethasone compared with Lenalidomide plus low-dose dexamethasone in the treatment of newly diagnosed multiple myeloma: prospective randomized phase III trial.
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Bortezomib (Primary) ; Aciclovir; Aspirin; Dexamethasone; Lenalidomide; Zoledronic acid
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Dec 2017 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology